S-MolSearch: 3D Semi-supervised Contrastive Learning for Bioactive Molecule Search
0
Sign in to get full access
Overview
- S-MolSearch is a 3D semi-supervised contrastive learning framework for bioactive molecule search.
- It learns expressive molecular representations by leveraging both labeled and unlabeled 3D molecular data.
- The approach aims to improve the efficiency and accuracy of virtual screening and drug discovery.
Plain English Explanation
S-MolSearch: 3D Semi-supervised Contrastive Learning for Bioactive Molecule Search is a new method for searching through large databases of 3D molecular structures to find potentially useful drug candidates.
The key idea is to use semi-supervised learning, which means using both labeled data (molecules with known properties) and unlabeled data (molecules without known properties) to learn better representations of the molecular structures. This is done through a contrastive learning approach, where the model tries to maximize the similarity between representations of the same molecule and minimize the similarity between representations of different molecules.
By learning these expressive molecular representations, the S-MolSearch framework can more efficiently screen large databases to identify promising drug candidates, potentially speeding up the drug discovery process. The 3D structural information is important, as it captures key details about how molecules interact with biological targets.
Technical Explanation
S-MolSearch: 3D Semi-supervised Contrastive Learning for Bioactive Molecule Search introduces a novel 3D semi-supervised contrastive learning framework for bioactive molecule search. The key components are:
- 3D Molecular Encoder: A 3D convolutional neural network that encodes 3D molecular structures into compact representations.
- Contrastive Learning: The model is trained to maximize the similarity between representations of the same molecule and minimize the similarity between representations of different molecules, leveraging both labeled and unlabeled 3D molecular data.
- Semi-supervised Learning: The use of both labeled and unlabeled data allows the model to learn more expressive molecular representations, improving the efficiency and accuracy of virtual screening.
The authors evaluated S-MolSearch on several benchmark datasets for virtual screening and found that it outperformed state-of-the-art 2D and 3D molecular representation learning methods. The 3D structural information and semi-supervised contrastive learning approach were both shown to be key to the improved performance.
Critical Analysis
The S-MolSearch paper presents a compelling approach to leveraging 3D molecular structure and semi-supervised learning for more effective bioactive molecule search. However, there are a few potential limitations and areas for further research:
- Sensitivity to 3D Conformations: The performance of the 3D molecular encoder may be sensitive to the quality and diversity of the 3D molecular conformations used during training. Robust handling of 3D conformation variability is an important challenge.
- Scalability to Large Databases: While the authors demonstrate the approach on benchmark datasets, its scalability to searching through extremely large real-world chemical libraries remains to be seen.
- Interpretability of Learned Representations: It would be helpful to better understand the specific molecular features and properties captured by the learned representations, to provide more insight into the model's decision-making.
Overall, the S-MolSearch framework represents an interesting and promising step forward in leveraging 3D structural information and semi-supervised learning for more effective virtual screening and drug discovery.
Conclusion
S-MolSearch: 3D Semi-supervised Contrastive Learning for Bioactive Molecule Search presents a novel 3D semi-supervised contrastive learning approach for bioactive molecule search. By learning expressive molecular representations that capture 3D structural information, the framework aims to improve the efficiency and accuracy of virtual screening and drug discovery.
The key innovations include a 3D molecular encoder, a contrastive learning objective that leverages both labeled and unlabeled data, and a semi-supervised learning approach. Experimental results demonstrate the effectiveness of this approach compared to state-of-the-art 2D and 3D molecular representation learning methods.
While the paper highlights some potential limitations, the S-MolSearch framework represents an exciting step forward in harnessing the power of 3D structural information and semi-supervised learning for more effective drug discovery. As the field continues to evolve, approaches like this could play an important role in accelerating the identification of promising drug candidates.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
S-MolSearch: 3D Semi-supervised Contrastive Learning for Bioactive Molecule Search
Gengmo Zhou, Zhen Wang, Feng Yu, Guolin Ke, Zhewei Wei, Zhifeng Gao
Virtual Screening is an essential technique in the early phases of drug discovery, aimed at identifying promising drug candidates from vast molecular libraries. Recently, ligand-based virtual screening has garnered significant attention due to its efficacy in conducting extensive database screenings without relying on specific protein-binding site information. Obtaining binding affinity data for complexes is highly expensive, resulting in a limited amount of available data that covers a relatively small chemical space. Moreover, these datasets contain a significant amount of inconsistent noise. It is challenging to identify an inductive bias that consistently maintains the integrity of molecular activity during data augmentation. To tackle these challenges, we propose S-MolSearch, the first framework to our knowledge, that leverages molecular 3D information and affinity information in semi-supervised contrastive learning for ligand-based virtual screening. Drawing on the principles of inverse optimal transport, S-MolSearch efficiently processes both labeled and unlabeled data, training molecular structural encoders while generating soft labels for the unlabeled data. This design allows S-MolSearch to adaptively utilize unlabeled data within the learning process. Empirically, S-MolSearch demonstrates superior performance on widely-used benchmarks LIT-PCBA and DUD-E. It surpasses both structure-based and ligand-based virtual screening methods for enrichment factors across 0.5%, 1% and 5%.
Read more9/14/2024
🔮
0
3D-Mol: A Novel Contrastive Learning Framework for Molecular Property Prediction with 3D Information
Taojie Kuang, Yiming Ren, Zhixiang Ren
Molecular property prediction, crucial for early drug candidate screening and optimization, has seen advancements with deep learning-based methods. While deep learning-based methods have advanced considerably, they often fall short in fully leveraging 3D spatial information. Specifically, current molecular encoding techniques tend to inadequately extract spatial information, leading to ambiguous representations where a single one might represent multiple distinct molecules. Moreover, existing molecular modeling methods focus predominantly on the most stable 3D conformations, neglecting other viable conformations present in reality. To address these issues, we propose 3D-Mol, a novel approach designed for more accurate spatial structure representation. It deconstructs molecules into three hierarchical graphs to better extract geometric information. Additionally, 3D-Mol leverages contrastive learning for pretraining on 20 million unlabeled data, treating their conformations with identical topological structures as weighted positive pairs and contrasting ones as negatives, based on the similarity of their 3D conformation descriptors and fingerprints. We compare 3D-Mol with various state-of-the-art baselines on 7 benchmarks and demonstrate our outstanding performance.
Read more7/1/2024
0
PharmacoMatch: Efficient 3D Pharmacophore Screening through Neural Subgraph Matching
Daniel Rose, Oliver Wieder, Thomas Seidel, Thierry Langer
The increasing size of screening libraries poses a significant challenge for the development of virtual screening methods for drug discovery, necessitating a re-evaluation of traditional approaches in the era of big data. Although 3D pharmacophore screening remains a prevalent technique, its application to very large datasets is limited by the computational cost associated with matching query pharmacophores to database ligands. In this study, we introduce PharmacoMatch, a novel contrastive learning approach based on neural subgraph matching. Our method reinterprets pharmacophore screening as an approximate subgraph matching problem and enables efficient querying of conformational databases by encoding query-target relationships in the embedding space. We conduct comprehensive evaluations of the learned representations and benchmark our method on virtual screening datasets in a zero-shot setting. Our findings demonstrate significantly shorter runtimes for pharmacophore matching, offering a promising speed-up for screening very large datasets.
Read more9/11/2024
0
Understanding active learning of molecular docking and its applications
Jeonghyeon Kim, Juno Nam, Seongok Ryu
With the advancing capabilities of computational methodologies and resources, ultra-large-scale virtual screening via molecular docking has emerged as a prominent strategy for in silico hit discovery. Given the exhaustive nature of ultra-large-scale virtual screening, active learning methodologies have garnered attention as a means to mitigate computational cost through iterative small-scale docking and machine learning model training. While the efficacy of active learning methodologies has been empirically validated in extant literature, a critical investigation remains in how surrogate models can predict docking score without considering three-dimensional structural features, such as receptor conformation and binding poses. In this paper, we thus investigate how active learning methodologies effectively predict docking scores using only 2D structures and under what circumstances they may work particularly well through benchmark studies encompassing six receptor targets. Our findings suggest that surrogate models tend to memorize structural patterns prevalent in high docking scored compounds obtained during acquisition steps. Despite this tendency, surrogate models demonstrate utility in virtual screening, as exemplified in the identification of actives from DUD-E dataset and high docking-scored compounds from EnamineReal library, a significantly larger set than the initial screening pool. Our comprehensive analysis underscores the reliability and potential applicability of active learning methodologies in virtual screening campaigns.
Read more6/21/2024